Chemours (CC) and Its Competitors Financial Review

Chemours (NYSE:CC) is one of 295 publicly-traded companies in the “Chemicals” industry, but how does it compare to its rivals? We will compare Chemours to related companies based on the strength of its earnings, risk, valuation, institutional ownership, analyst recommendations, profitability and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for Chemours and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2	8	3	0	2.08
Chemours Competitors	3248	12216	14134	519	2.40

Chemours presently has a consensus target price of $17.45, indicating a potential upside of 32.49%. As a group, “Chemicals” companies have a potential upside of 8.33%. Given Chemours’ higher probable upside, research analysts clearly believe Chemours is more favorable than its rivals.

Institutional and Insider Ownership

76.3% of Chemours shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 13.9% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Chemours and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Chemours	$5.81 billion	-$386.00 million	-12.92
Chemours Competitors	$8.01 billion	$230.87 million	9.81

Chemours’ rivals have higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Chemours has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, Chemours’ rivals have a beta of 0.93, indicating that their average share price is 7% less volatile than the S&P 500.

Dividends

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.7%. Chemours pays out -34.3% of its earnings in the form of a dividend. As a group, “Chemicals” companies pay a dividend yield of 3.1% and pay out 103.9% of their earnings in the form of a dividend.

Profitability

This table compares Chemours and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Chemours	-2.64%	76.52%	1.51%
Chemours Competitors	-59.15%	-0.44%	-1.38%

Summary

Chemours rivals beat Chemours on 8 of the 15 factors compared.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.